The Persistence of Autoantibody Neutralisation by BC 007 in Patients With Chronic HFrEF and Autoantibodies Against the Beta1-Adrenergic Receptor
Clinical trial NCT04192214 · COMPLETED
Trial details
- NCT number
- NCT04192214
- Sponsor
- Berlin Cures GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-29
- Primary completion
- 2022-12-06
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.